Abstract
In rodents, bovine (b) growth hormone (GH) binds only to GH receptors, while human (h) GH binds to both GH and PRL receptors. The phenotypic consequences of expression of bGH and hGH in transgenic mice are different and, in some cases, opposite. In the present study, site-directed in vitro mutagenesis of the bGH gene was used systematically to eliminate its differences from hGH at one, two, three or four sites suspected of conferring lactogenic activity: D11, H18, S57 and T60, respectively (corresponding to sites 12, 19, 57 and 60 of the bGH molecule). The resulting bGH analogues were expressed in cell lines and in transgenic mice. All of the seven bGH analogues produced retained their ability to bind to GH receptors and exhibited somatogenic activity in vitro and in vivo. However, none of them were able to bind to PRL receptors or to elicit detectable lactogenic response in vitro. Transgenic animals expressing any of the generated analogues were characterized by gigantism and splanchnomegaly. The effects of expression of each of the double, triple or quadruple mutants on the seminal vesicle weight resembled the effects of wild-type hGH and differed from the effects of expression of wild-type bGH. There were differences between the effects of the expression of different bGH analogues on plasma PRL levels and on the PRL response to pharmacological blockade of catecholamine synthesis. Plasma LH levels in ovariectomized females were suppressed by several of the analogues tested, an effect not seen in animals expressing wild-type bGH or hGH. Dopamine turnover in the median eminence of male mice was also altered in animals expressing different bGH analogues but not in those expressing wild-type bGH or hGH. In ovariectomized females, the effects of different bGH analogs on the turnover of dopamine and norepine phrine in the median eminence included changes resembling those detected in animals expressing hGH, as well as alterations differing from the effects of bot h bGH and hGH.
The results indicate that biological actions of these bGH analogues cannot be characterized simply in terms of enhanced or reduced somatogenic or lactogenic activity and raise a possibility that different sites, domains or features of the tri-dimensional structure of GH are involved in its actions on different cellular targets
Similar content being viewed by others
References
Bartke, A., Steger, R.W., Hodges, S.L., Parkening, T.A., Collins, T.J., Yun, J.S. and Wagner, T.E. (1988) Infertility in transgenic female mice with human growth hormone expression: Evidence for luteal failure. J. Exp. Zool. 248, 121-4.
Bartke, A., Naar, E.M., Johnson, L., May, M.R., Cecim, M., Yun, J.S. and Wagner, T.E. (1992) Effects of expression of human or bovine growth hormone genes on sperm production and male reproductive performance in four lines of transgenic mice. J. Reprod. Fertil. 95, 109-18.
Bartke, A., Cecim, M., Tang, K., Steger, R.W., Chandrashekar, V. and Turyn, D. (1994) Neuroendocrine and reproductive consequences of overexpression of growth hormone in transgenic mice. J. Exp. Biol. Med. 206, 345-59.
Cecim, M., Bartke, A., Yun, J.S. and Wagner, T.E. (1994) Expression of human, but not bovine growth hormone genes promotes development of mammary tumors in transgenic mice. Transgenics 1, 431-7.
Chandrashekar, V., Bartke, A. and Wagner, T.E. (1988) Endogenous human growth hormone (GH) modulates the effect of gonadotropin-releasing hormone on pituitary function and the gonadotropin response to the negative feedback effect of testosterone in adult male transgenic mice bearing human GH gene. Endocrinology 123, 2717-22.
Chandrashekar, V., Bartke, A. and Wagner, T.E. (1992) Neuroendocrine function in adult female transgenic mice expressing the human growth hormone gene. Endocrinology 130, 1802-8.
Chen, X.Z., Shafer, A.W., Yun, J.S., Li, Y.S., Wagner, T.E. and Kopchick, J.J. (1992) Conversion of bovine growth hormone cysteine residues to serine affects secretion by cultured cells and growth rates in transgenic mice. Mol. Endocrinol. 5, 598-606.
Cunningham, B.C., Grass, S., Fuh, G. and Wells, J.A. (1990a) Zinc mediation of the binding of human growth hormone to the human prolactin receptor. Science 250, 1709-12.
Cunningham, B.C., Henner, D.J. and Wells, J.A. (1990b) Engineering human prolactin to bind to the human growth hormone receptor. Science 247, 1461-5.
de Boer H., Blok, G.J. and Van der Veen, E.A. (1995) Clinical aspects of growth hormone deficiency in adults. Endocr. Rev. 16, 63-86.
Forsyth, I.A., Folley, S.J. and Chadwick, A. (1965) Lactogenic and pigeon crop-stimulating activities of human pituitary growth hormone preparation. J. Endocrinol. 31, 115-26.
Gout, P.W., Noble, R.L. and Beer, C.T. (1986) Cultured Nb rat lymphoma cells in endocrine and cancer research. Biochem. Cell Biol. 64, 659-66.
Jorgensen, J.O.L. (1991) Human growth hormone replacement therapy: pharmacological and clinical aspects. Endocr. Rev. 12, 189-207.
Kunkel, T.A. (1985) Oligonucleotide-directed mutagenesis. Proc. Natl Acad. Sci. USA 82, 488-92.
Mayo, K.E., Hammer, R.E., Swanson, L.W., Brinster, R.L., Rosenfeld, M.G. and Evans, R.M. (1988) Dramatic pituitary hyperplasia in transgenic mice expressing a human growth hormone releasing factor gene. Mol. Endocrinol. 2, 606-12.
Nicoll, C.S., Mayer, G.L. and Russell, S.M. (1986) Structural features of prolactins and growth hormones that can be related to their biological properties. Endocr. Rev. 7, 169-203.
Orian, J.M., Lee, C.S., Weiss, L.M. and Brandon, M.R. (1989) The expression of a metallothionein-ovine growth hormone fusion gene in transgenic mice does not impair fertility but results in pathological lesions in the liver. Endocrinology 124, 455-63.
Palmiter, R.D., Brinster, R.L., Hammer, R.E. (1982) Dramatic growth of mice that develop from eggs microinjected with metallothionein-growth hormone fusion genes. Nature 300, 611-15.
Posner, B.I., Kelly, P.A., Shiu, R.P.C., Paud, R. and Friesen, H.G. (1974) Studies of insulin, growth hormone and prolactin binding: tissue distribution, species variation and characterization. Endocrinology 95, 521-31.
Prins, G.S., Cecim, M., Birch, L., Wagner, T.E. and Bartke, A. (1992) Growth response and androgen receptor expression in seminal vesicles from aging transgenic mice expressing human or bovine growth hormone genes. Endocrinology 131, 2016-23.
Sanger, F., Niklen, S. and Coulson, A.R. (1977) DNA sequencing with chain-terminating inhibitors. Proc. Natl Acad. Sci. USA 76, 4350-4.
Selden, R.F., Wagner, T.E., Blethen, S., Yun, J.S., Rowe, M.E. and Goodman, H.M. (1988) Expression of the human growth hormone variant in cultured fibroblasts and transgenic mice. Proc. Natl Acad. Sci. USA 85, 8241-5.
Shea, B.T., Hammer, R.E. and Brinster, R.L. (1987) Growth allometry of the organs in giant transgenic mice. Endocrinology 121, 1924-30.
Sotelo, A.I., Bartke, A. and Turyn, D. (1993) Effects of bovine growth hormone (GH) expression in transgenic mice on serum and pituitary immunoreactive mouse GH levels and pituitary GH-releasing factor binding sites. Acta Endocrinol. 129, 446-52.
Stefaneanu, L., Kovacs, K., Horvarth, N.E., Losinski, E., Mayerhofer, A., Wagner, T.E. and Bartke, A. (1990) An immunocytochemical and ultrastructural study of adenohypophyses of mice transgenic for human growth hormone. Endocrinology 126, 608-15.
Stefaneanu, L., Kovacs, K., Bartke, A., Mayerhofer, A. and Wagner, T.E. (1993) Pituitary morphology of transgenic mice expressing bovine growth hormone. Lab. Invest. 68, 584-91.
Steger, R.W., DePaolo, L.V., Asch, R.H. and Silverman, A.Y. (1983) Interactions of delta 9-tetrahydrocannabinol (THC) with hypothalamic neurotransmitters controlling luteinizing hormone and prolactin release. Neuroendocrinology 37, 361-70.
Steger, R.W., Bartke, A., Parkening, T.A., Collins, T., Yun, J.S. and Wagner, T.E. (1990) Neuroendocrine function in transgenic male mice with human growth hormone expression. Neuroendocrinology 52, 106-11.
Steger, R.W., Bartke, A., Parkening, T.A., Collins, T., Buonomo, F., Tang, K., Wagner, T.E. and Yun, J.S. (1991) Effects of heterologous growth hormones on hypothalamic and pituitary function in transgenic mice. Neuroendocrinology 53, 365-72.
Steger, R.W., Bartke, A., Parkening, T.A., Collins, T., Cerven, R., Yun, J.S. and Wagner, T.E. (1994) Effects of chronic exposure to bovine growth hormone (bGH)) on the hypothalamic-pituitary axis in transgenic mice: Relationship to the degree of expression of the PEPCK-bGH hybrid gene. Transgenics 1, 245-53.
Ultsch, M. and de Vos, A.M. (1993) Crystals of human growth hormone-receptor complexes. Extracellular domains of the growth hormone and prolactin receptors and a hormone mutant designed to prevent dimerization. J. Mol. Biol. 231, 1133-6.
Vidal, S., Stefaneanu, L., Kovacs, K. and Bartke, A. (1996) Gene expression of estrogen and dopamine subtype 2 receptors in transgenic mice with overproduction of heterologous growth hormones. Endocr. Soc., Abstract P3-217, p. 809.
Wagner, T.E., Hoppe, P.C., Jollick, J.D., Scholl, D.R., Hodinka, R.L. and Gault, J.B. (1981) Microinjection of a rabbit β-globulin gene into zygotes and its subsequent expression in adult mice and their offspring. Proc. Natl Acad. Sci. USA 78, 6376-80.
Wang, W., Xu, B., Souza, S.C. and Kopchick, J.J. (1994) Growth hormone (GH) induces tyrosine-phosphorylated proteins in mouse L cells which express recombinant GH receptors. Proc. Natl Acad. Sci. USA 91, 1391-95.
Xu, B.C., Wang, X., Danis, C.J. and Kopchick, J.J. (1996) Growth hormone receptor prompts the association of prereceptor factor STATS with the growth hormone receptor. J. Biol. Chem. 271, 19768-73.
Yang, C.W., Striker, L.J., Kopchick, J.J., Chen, W.Y., Pesce, C.M., Peten, E.P. and Striker, G.E. (1993a) Glomerulosclerosis in mice transgenic for native or mutated bovine growth hormone gene. Kid. Internat. 43, S90-4.
Yang, C.W., Striker, L.J., Pesce, C., Chen, W.Y., Paten, E.P., Elliot, S., Doi, T., Kopchick, J.J. and Striker, G.E. (1993b) Glomerulosclerosis and body growth are mediated by different portions of bovine growth hormone: studies in transgenic mice. Lab. Invest. 68, 62-70.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kopchick, J., Chen, X.Z., Li, Y. et al. Differential in vivo activities of bovine growth hormone analogues. Transgenic Res 7, 61–71 (1998). https://doi.org/10.1023/A:1008808106353
Issue Date:
DOI: https://doi.org/10.1023/A:1008808106353